Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
about
Selection Criteria and Current Issues in Liver Transplantation for Hepatocellular CarcinomaMuscle dysfunction in cancer patientsThe evaluation of body composition: a useful tool for clinical practiceBody composition changes in females treated for breast cancer: a review of the evidenceCachexia and pancreatic cancer: are there treatment options?Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literatureMeasuring Abdominal Circumference and Skeletal Muscle From a Single Cross-Sectional Computed Tomography Image: A Step-by-Step Guide for Clinicians Using National Institutes of Health ImageJCancer cachexia: impact, mechanisms and emerging treatmentsLower Pectoralis Muscle Area Is Associated with a Worse Overall Survival in Non-Small Cell Lung CancerClinical classification of cancer cachexia: phenotypic correlates in human skeletal muscleEpidemiology of sarcopenia and insight into possible therapeutic targets.Home-based functional walking program for advanced cancer patients receiving palliative care: a case series.Inflammation based regulation of cancer cachexiaConcurrent evolution of cancer cachexia and heart failure: bilateral effects exist.Changes in nutritional status after liver transplantationBody composition, symptoms, and survival in advanced cancer patients referred to a phase I serviceUnderstanding cancer-induced cachexia: imaging the flame and its fuel.Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle.Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Pancreatic cancer cachexia: a review of mechanisms and therapeutics.An Epidemiological Survey of Cachexia in Advanced Cancer Patients and Analysis on Its Diagnostic and Treatment Status.Sarcopenia as a prognostic biomarker of advanced urothelial carcinomaThe regulation of muscle mass by endogenous glucocorticoids.Intramyocellular lipid droplets increase with progression of cachexia in cancer patientsSarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumorsSarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancerSarcopenia: burden and challenges for public health.Muscle mass predicts outcomes following liver transplantationAre sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinomaAdvances in the science and application of body composition measurementThe effect of individualized nutritional counseling on muscle mass and treatment outcome in patients with metastatic colorectal cancer undergoing chemotherapy: a randomized controlled trial protocolSkeletal muscle myotubes in severe obesity exhibit altered ubiquitin-proteasome and autophagic/lysosomal proteolytic fluxNegative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal CancerSarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer CachexiaSkeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenibSkeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
P2860
Q26744102-CF1C1E4F-FEB6-4E4E-82AB-F350796AE86AQ26822365-DEE5AC28-2CF2-4252-AECE-3BA8DD9D1E13Q26825173-8EA41BF0-547A-40C5-85B8-27F63B87A4AAQ27004662-14DD4465-64A7-45F3-963B-9C1930684188Q27026558-4A4BEA62-7911-4461-A461-C488E022B1FAQ28068034-49C9E3D2-786C-4EB9-A869-ECADD364225DQ28081125-4E541537-A9AB-41D4-B9D9-DE74D7F066B0Q28364529-818E6DD0-8980-47B0-B365-0805058FC5C4Q28384479-6D163DE1-5509-4027-A49F-03B943AF526EQ28394473-4FE5B99C-A0CC-4CEB-AE3A-EB39E2394DE1Q28538296-38F144B0-8728-41F5-AFE9-3A439D5460AEQ30234579-7DFBE9BC-5CF0-4580-894F-D56451D86931Q30539855-DFDB099D-1EA6-438B-9D51-16F7EF1E4569Q33615916-5177AEE7-E8BB-434D-B9E9-AAF8DBAAC702Q33741091-D764C0FD-839A-4C1F-AE4D-7CAB6AA8AC1FQ34067831-88354201-01D6-40DE-8385-1856A9B5B54EQ34123648-F221A038-4375-4874-97A9-A47CA51180FBQ34138093-EFA836DC-05FE-42A2-9D3F-318DB058E8CFQ34257035-4F50B0E2-DFA9-4EC4-85C4-67BBF833703CQ34315320-FC73FC1A-8EA6-4D05-8A43-5A81205F9307Q34660312-7E806815-D526-40A3-8151-3C4BB24B63A4Q34672667-70BF8632-CC71-4F65-8CBD-38AB8397EF8DQ35001652-C135549C-D42B-46A6-A109-DD2BD499BEE8Q35042169-A59A36D4-2625-4DB2-A287-DB1FD06928C1Q35053586-1720BD46-CE96-4BB0-8082-57F59AF8A322Q35096126-A9A88C9E-A9DA-40CE-9886-CA3EF97C75EFQ35097594-936A70DC-08CB-46E9-A5F8-9AA0C7403A0DQ35166583-0CA96874-3EEA-470C-9D00-BA712D2D48CCQ35215893-55062A4D-BAE9-4FCA-ABA9-96C467DA978AQ35246800-3FBCF935-651C-4909-AA7D-67CE15DB942EQ35469145-EA5F2F4A-6D2C-42EA-BA69-DB51E7570303Q35528619-134B7A37-B13F-4D9D-891B-2B32B8296748Q35575554-C0D569B3-28B3-4308-AC5D-EA64B66C62C4Q35605586-68CE6FC1-741A-4DC6-A018-9CDCD281E021Q35652814-6CEEDF75-94E7-4A9F-841B-C490C448BC61Q35662253-0FA64977-7516-4E77-9D3F-EA0A5C7DD27CQ35690204-CA1F4D71-F3BB-45E0-9418-30920D9572F9Q35690582-BA4CCD1E-AE9D-4476-8746-93E40476BF79Q35722941-6C57DDF3-821C-4FCB-9DF2-AF75605A40B4Q35799268-3057E0DD-D2D0-44BE-B5F7-BBE6B7217A3F
P2860
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
description
im November 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 November 2009
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2009
@uk
name
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@en
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@nl
type
label
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@en
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@nl
prefLabel
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@en
Sarcopenia in an Overweight or ...... ic Factor in Pancreatic Cancer
@nl
P2093
P1476
Sarcopenia in an overweight or ...... ic factor in pancreatic cancer
@en
P2093
Benjamin H L Tan
Kenneth C H Fearon
Laura A Birdsell
Lisa Martin
P304
P356
10.1158/1078-0432.CCR-09-1525
P407
P577
2009-11-03T00:00:00Z